Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

